Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 36.8263.14-3.4820.95965.63

What is the latest Core EBITDA Growth ratio of ORCHID PHARMA ?

The latest Core EBITDA Growth ratio of ORCHID PHARMA is 36.82 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202436.82
Mar202363.14
Mar2022-3.48
Mar202120.95
Mar2020965.63

How is Core EBITDA Growth of ORCHID PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 36.82
-41.69
Mar2023 63.14
Positive
Mar2022 -3.48
Negative
Mar2021 20.95
-97.83
Mar2020 965.63 -

Other Financial Ratios of ORCHID PHARMA


Compare Core EBITDA Growth ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹4,230.7 Cr 4.1% 1.6% -23.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 5.4% 3.2% 20.4% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 1.9% 2% 59.4% Stock Analytics
CIPLA ₹124,457.0 Cr 1.7% 2% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr 2.8% 2.3% 22.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr 2.1% -0.9% -1.5% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

4.1%

1.6%

-23.7%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses